Hancock Whitney’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Buy
33,081
+9
+0% +$205 0.01% 471
2026
Q1
$744K Sell
33,072
-1,139
-3% -$23.7K 0.01% 482
2025
Q4
$732K Buy
34,211
+510
+2% +$10.5K 0.01% 476
2025
Q3
$565K Buy
33,701
+7,772
+30% +$116K 0.01% 536
2025
Q2
$372K Buy
25,929
+11,107
+75% +$152K 0.01% 620
2025
Q1
$215K Buy
14,822
+2,656
+22% +$37.7K 0.01% 620
2024
Q4
$160K Buy
+12,166
New +$168K 0.01% 624
2019
Q4
Sell
-118,597
Closed -$2.68M 849
2019
Q3
$2.68M Buy
118,597
+1
+0% +$23 0.09% 256
2019
Q2
$2.99M Buy
118,596
+2,504
+2% +$67.3K 0.1% 251
2019
Q1
$3.15M Buy
116,092
+2,570
+2% +$86.2K 0.1% 246
2018
Q4
$3.75M Sell
113,522
-126,547
-53% -$5.09M 0.13% 222
2018
Q3
$11.2M Buy
240,069
+408
+0.2% +$18.7K 0.32% 95
2018
Q2
$10.4M Buy
+239,661
New +$11.5M 0.48% 78
2014
Q3
Sell
-49,344
Closed -$2.87M 513
2014
Q2
$2.87M Buy
49,344
+5,755
+13% +$339K 0.1% 226
2014
Q1
$2.7M Buy
43,589
+645
+2% +$37.5K 0.11% 219
2013
Q4
$2.29M Sell
42,944
-382
-0.9% -$20.5K 0.09% 228
2013
Q3
$2.17M Sell
43,326
-4,886
-10% -$238K 0.1% 219
2013
Q2
$2.21M Buy
+48,212
New +$2.16M 0.11% 214

Other funds holding MD

Hancock Whitney's MD Position: Q2 2026 in Review

Hancock Whitney increased its Pediatrix Medical (MD) stake by 0.03% in Q2 2026, buying an estimated $205 and bringing the position to 33,081 shares worth $838K. The position accounts for 0.01% of the portfolio, ranked #471.

Hancock Whitney first reported a position in MD in Q2 2013 and has held it in 18 quarters since. The position peaked at $11.2M in Q3 2018. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Hancock Whitney held 33,081 shares of Pediatrix Medical worth $838K as of Q2 2026.
  • Hancock Whitney bought 9 Pediatrix Medical shares in Q2 2026, an estimated $205.
  • Pediatrix Medical made up 0.01% of Hancock Whitney's portfolio in Q2 2026, its #471 holding.
  • Hancock Whitney first reported a position in Pediatrix Medical in Q2 2013 and has held it in 18 quarters since.
  • Hancock Whitney's Pediatrix Medical position peaked at $11.2M in Q3 2018.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.